Claim your 7-day free trial now. In a stark contrast to Elon Musk‘s $364 billion fortune, his first wife Justine Wilson Musk is worth just $15 million. What Happened: Justine Musk’s net worth ...

Indeed, years later, backed first by Partovi, Truell co-founded Anysphere, maker of the popular AI-powered coding editor Cursor, which is now flirting with a $10 billion valuation and may become ...

In 2025, pharmacy leaders are grappling with a billion-dollar question: how to deliver high-quality, patient-centered care amid financial strain, policy uncertainty, and rapid technological change.

Republican lawmakers say districts are holding a record $10.5 billion in cash reserves, and the 30% cap would amount to $4 billion in immediate property tax relief. School districts say it would ...

Aon plc reported steady growth in the first quarter of 2025, with revenue climbing 16 per cent to $4.7 billion compared to the same period last year, despite a tougher global economic environment ...

Myers has continued playing the tech mogul on SNL, even throwing in a bit of his iconic Dr. Evil character from Austin Powers. It seems that Myers has taken particular issue with Musk and the current ...

Canadian celebrities are also pushing back including comedian Mike Myers, as he returned to "Saturday Night Live" in March, impersonating Tesla CEO and Trump adviser Elon Musk as Dr Evil from ...

Allen thinks DC won’t see a return on its billion-dollar investment, and that the development of more subsidized housing on the site would be a better deal for the neighborhood. Council chair Phil ...

"We've put a lot of money into the market, over a billion dollars a year supporting third-party games coming into Game Pass. "What we see in Game Pass is a service that supports all kinds of games ...

It’s worth taking a moment to put this number into some context in case half a trillion dollars doesn’t do ... For 2023 that number was $917 billion. So that’s most of the stuff we think ...

The company now employs 500 people, has a research hub in Sydney and a market capitalisation of $1.4 billion.

Bought into the fold through the $5.8 billion acquisition of Stemcentrx in 2016, Rova-T – short for rovalpituzumab tesirine – had a great name and some tasty looking results from an early-to ...